Form 4: Protagonist Therapeutics CEO Sells Shares to Cover Tax Obligations
SEC Form 4 Filing
Dinesh V. Patel, CEO of Protagonist Therapeutics, sold shares to cover tax obligations related to vesting restricted stock units.
Summary
- On February 26, 2024, Dinesh V. Patel, the President and CEO of Protagonist Therapeutics, Inc., disposed of 10,915 shares of common stock to satisfy tax withholding obligations.
- The shares were sold at a price of $29.53 per share.
- Following the transaction, Patel directly owns 604,590 shares of Protagonist Therapeutics.
Sentiment
Score: 5
Explanation: The document is a routine regulatory filing related to stock transactions by a company insider. It doesn't inherently convey positive or negative sentiment.
Industry Context
Form 4 filings are standard practice for company insiders and officers, like the CEO, to report transactions in their company's stock. These filings are publicly available and provide transparency into insider trading activities.
Stakeholder Impact
- The transaction has a minimal impact on stakeholders as it is a routine sale of shares to cover tax obligations.
Key Dates
| Date | Description |
|---|---|
| 02/26/2024 | Date of transaction: Disposal of shares to cover tax obligations. |
| 02/28/2024 | Date of signature on the Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.